Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
复制标题
DOI:
10.1038/nature13611
复制
发表时间:
2014-10-30
期刊:
影响因子:
64.8
通讯作者:
Draetta, Giulio F.
中科院分区:
文献类型:
--
作者:
Viale, Andrea;Pettazzoni, Piergiorgio;Lyssiotis, Costas A.;Ying, Haoqiang;Sanchez, Nora;Marchesini, Matteo;Carugo, Alessandro;Green, Tessa;Seth, Sahil;Giuliani, Virginia;Kost-Alimova, Maria;Muller, Florian;Colla, Simona;Nezi, Luigi;Genovese, Giannicola;Deem, Angela K.;Kapoor, Avnish;Yao, Wantong;Brunetto, Emanuela;Kang, Ya'an;Yuan, Min;Asara, John M.;Wang, Y. Alan;Heffernan, Timothy P.;Kimmelman, Alec C.;Wang, Huamin;Fleming, Jason B.;Cantley, Lewis C.;DePinho, Ronald A.;Draetta, Giulio F.
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients.KRASmutations are known to be a driver event of PDAC, but targeting mutantKRAShas proved challenging. Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases,. Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling,. Here we explore the role of mutantKRASin PDAC maintenance using a recently developed inducible mouse model of mutatedKras(KrasG12D, herein KRas) in a p53LoxP/WTbackground. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of theKRASpathway and mitochondrial respiration to manage pancreatic cancer.
登录
查看更多内容
影响因子:
23.9
作者:
Lagadinou, Eleni D.;Sach, Alexander;Callahan, Kevin;Rossi, Randall M.;Neering, Sarah J.;Minhajuddin, Mohammad;Ashton, John M.;Pei, Shanshan;Grose, Valerie;O'Dwyer, Kristen M.;Liesveld, Jane L.;Brookes, Paul S.;Becker, Michael W.;Jordan, Craig T.
通讯作者:
Jordan, Craig T.
影响因子:
14.8
作者:
通讯作者:
--
影响因子:
50.3
作者:
Skrtić M;Sriskanthadevan S;Jhas B;Gebbia M;Wang X;Wang Z;Hurren R;Jitkova Y;Gronda M;Maclean N;Lai CK;Eberhard Y;Bartoszko J;Spagnuolo P;Rutledge AC;Datti A;Ketela T;Moffat J;Robinson BH;Cameron JH;Wrana J;Eaves CJ;Minden MD;Wang JC;Dick JE;Humphries K;Nislow C;Giaever G;Schimmer AD
通讯作者:
Schimmer AD
影响因子:
9.9
作者:
Gaglio, Daniela;Metallo, Christian M.;Chiaradonna, Ferdinando
通讯作者:
Chiaradonna, Ferdinando
影响因子:
10.5
作者:
Guo, Jessie Yanxiang;Chen, Hsin-Yi;White, Eileen
通讯作者:
White, Eileen